Polymorphisms in inflammatory and immune response genes associated with cerebral cavernous malformation type 1 severity

Cerebrovascular Diseases

Volumn 38, Issue 6, 2014, Pages 433-440

  Choquet, Hélène ^a   Pawlikowska, Ludmila ^a,b   Nelson, Jeffrey ^a   McCulloch, Charles E ^a   Akers, Amy ^c   Baca, Beth ^d   Khan, Yasir ^d   Hart, Blaine ^d   Morrison, Leslie ^d   Kim, Helen ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Angioma Alliance   (United States)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Brain lesion count; CCM1 disease severity; Cerebral cavernous malformation; Inflammation and immune response modifier genes; Intracerebral hemorrhage

Indexed keywords

CD14 ANTIGEN; ICOSANOID; INTERLEUKIN 4; INTERLEUKIN 6 RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; IL4 PROTEIN, HUMAN; KRIT1 PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; MSR1 PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN SERINE THREONINE KINASE; SCAVENGER RECEPTOR A; TLR4 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

ADULT; ARTICLE; BRAIN HEMORRHAGE; CAVERNOUS HEMANGIOMA; CLINICAL ASSESSMENT; DISEASE SEVERITY; FEMALE; GENE; GENETIC SUSCEPTIBILITY; GENOTYPE; HERITABILITY; HETEROZYGOTE; HISPANIC; HUMAN; IMMUNE RESPONSE GENE; KRIT1 GENE; MAJOR CLINICAL STUDY; MALE; PATTERN RECOGNITION; PHENOTYPE; PRIORITY JOURNAL; SUSCEPTIBILITY WEIGHTED IMAGING; ADOLESCENT; AGED; BRAIN; BRAIN HEMANGIOMA; CEREBRAL HEMORRHAGE; CHILD; COMPLICATION; GENETIC POLYMORPHISM; GENETICS; INFLAMMATION; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; SEVERITY OF ILLNESS INDEX; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD14; BRAIN; CEREBRAL HEMORRHAGE; CHILD; FEMALE; GENES, MHC CLASS II; HEMANGIOMA, CAVERNOUS, CENTRAL NERVOUS SYSTEM; HISPANIC AMERICANS; HUMANS; INFLAMMATION; INTERLEUKIN-4; MAGNETIC RESONANCE IMAGING; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; POLYMORPHISM, GENETIC; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RECEPTORS, INTERLEUKIN-6; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SCAVENGER RECEPTORS, CLASS A; SEVERITY OF ILLNESS INDEX; TOLL-LIKE RECEPTOR 4; YOUNG ADULT;

EID: 84917707413     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000369200     Document Type: Article

References (39)

1. Choquet H, Nelson J, Pawlikowska L, Mc- Culloch CE, Akers A, Baca B, Khan Y, Hart B, Morrison L, Kim H: Association of cardiovascular risk factors with disease severity in cerebral cavernous malformation type 1 subjects with the common Hispanic mutation. Cerebrovasc Dis 2014; 37: 57-63.
2. Denier C, Labauge P, Brunereau L, Cave-Riant F, Marchelli F, Arnoult M, Cecillon M, Maciazek J, Joutel A, Tournier-Lasserve E: Clinical features of cerebral cavernous malformations patients with KRIT1 mutations. Ann Neurol 2004; 55: 213-220.
3. Morrison L, Akers A: Cerebral cavernous malformation, familial; in Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP (eds): Gene Reviews. Seattle, University of Washington, 2003. Available at http://www.genetests.org (updated May 31, 2011).
4. Shenkar R, Shi C, Check IJ, Lipton HL, Awad IA: Concepts and hypotheses: inflammatory hypothesis in the pathogenesis of cerebral cavernous malformations. Neurosurgery 2007; 61: 693-702.
5. Shi C, Shenkar R, Batjer HH, Check IJ, Awad IA: Oligoclonal immune response in cerebral cavernous malformations. Laboratory investigation. J Neurosurg 2007; 107: 1023-1026.
6. Shi C, Shenkar R, Du H, Duckworth E, Raja H, Batjer HH, Awad IA: Immune response in human cerebral cavernous malformations. Stroke 2009; 40: 1659-1665.
7. Shi C, Shenkar R, Kinloch A, Henderson SG, Shaaya M, Chong AS, Clark MR, Awad IA: Immune complex formation and in situ B-cell clonal expansion in human cerebral cavernous malformations. J Neuroimmunol 2014; 272: 67-75.
8. Vymazal J, Brooks RA, Baumgarner C, Tran V, Katz D, Bulte JW, Bauminger R, Di Chiro G: The relation between brain iron and NMR relaxation times: an in vitro study. Magn Reson Med 1996; 35: 56-61.
9. Plummer NW, Gallione CJ, Srinivasan S, Zawistowski JS, Louis DN, Marchuk DA: Loss of p53 sensitizes mice with a mutation in Ccm1 (KRIT1) to development of cerebral vascular malformations. Am J Pathol 2004; 165: 1509-1518.
10. Maddaluno L, Rudini N, Cuttano R, Bravi L, Giampietro C, Corada M, Ferrarini L, Orsenigo F, Papa E, Boulday G, Tournier-Lasserve E, Chapon F, Richichi C, Retta SF, Lampugnani MG, Dejana E: EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature 2013; 498: 492-496.
11. Shenkar R, Elliott JP, Diener K, Gault J, Hu LJ, Cohrs RJ, Phang T, Hunter L, Breeze RE, Awad IA: Differential gene expression in human cerebrovascular malformations. Neurosurgery 2003; 52: 465-478.
12. Achrol AS, Pawlikowska L, McCulloch CE, Poon KY, Ha C, Zaroff JG, Johnston SC, Lee C, Lawton MT, Sidney S, Marchuk DA, Kwok PY, Young WL: Tumor necrosis factor-alpha- 238G>A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations. Stroke 2006; 37: 231-234.
13. Chen Y, Pawlikowska L, Yao JS, Shen F, Zhai W, Achrol AS, Lawton MT, Kwok PY, Yang GY, Young WL: Interleukin-6 involvement in brain arteriovenous malformations. Ann Neurol 2006; 59: 72-80.
14. Fontanella M, Rubino E, Crobeddu E, Gallone S, Gentile S, Garbossa D, Ducati A, Pinessi L, Rainero I: Brain arteriovenous malformations are associated with interleukin-1 cluster gene polymorphisms. Neurosurgery 2012; 70: 12-17.
15. Kim H, Hysi PG, Pawlikowska L, Poon A, Burchard EG, Zaroff JG, Sidney S, Ko NU, Achrol AS, Lawton MT, McCulloch CE, Kwok PY, Young WL: Common variants in interleukin-1-beta gene are associated with intracranial hemorrhage and susceptibility to brain arteriovenous malformation. Cerebrovasc Dis 2009; 27: 176-182.
16. Pawlikowska L, Tran MN, Achrol AS, Mc- Culloch CE, Ha C, Lind DL, Hashimoto T, Zaroff J, Lawton MT, Marchuk DA, Kwok PY, Young WL: Polymorphisms in genes involved in inflammatory and angiogenic pathways and the risk of hemorrhagic presentation of brain arteriovenous malformations. Stroke 2004; 35: 2294-2300.
17. Slowik A, Borratynska A, Turaj W, Pera J, Dziedzic T, Wloch D, Szczudlik A, Betlej M, Krzyszkowski T, Czepko R: Interleukin 1beta- 511 C/T polymorphism and risk of aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 2006; 77: 279-280.
18. Al-Shahi Salman R, Berg MJ, Morrison L, Awad IA: Hemorrhage from cerebral cavernous malformations of the brain: definition and reporting standards. Angioma Alliance Scientific Advisory Board. Stroke 2008; 39: 3222-3230.
19. Hoffmann TJ, Zhan Y, Kvale MN, Hesselson SE, Gollub J, Iribarren C, Lu Y, Mei G, Purdy MM, Quesenberry C, Rowell S, Shapero MH, Smethurst D, Somkin CP, Van den Eeden SK, Walter L, Webster T, Whitmer RA, Finn A, Schaefer C, Kwok PY, Risch N: Design and coverage of high throughput genotyping arrays optimized for individuals of East Asian, African American, and Latino race/ethnicity using imputation and a novel hybrid SNP selection algorithm. Genomics 2011; 98: 422-430.
20. Kim H, Marchuk DA, Pawlikowska L, Chen Y, Su H, Yang GY, Young WL: Genetic considerations relevant to intracranial hemorrhage and brain arteriovenous malformations. Acta Neurochir Suppl 2008; 105: 199-206.
21. Kaczorowski DJ, Mollen KP, Edmonds R, Billiar TR: Early events in the recognition of danger signals after tissue injury. J Leukoc Biol 2008; 83: 546-552.
22. Wang Y, Ge P, Zhu Y: TLR2 and TLR4 in the brain injury caused by cerebral ischemia and reperfusion. Mediators Inflamm 2013; 2013: 124614.
23. Winters L, Winters T, Gorup D, Mitrecic D, Curlin M, Kriz J, Gajovic S: Expression analysis of genes involved in TLR2-related signaling pathway: inflammation and apoptosis after ischemic brain injury. Neuroscience 2013; 238: 87-96.
24. Colaizzo D, Fofi L, Tiscia G, Guglielmi R, Cocomazzi N, Prencipe M, Margaglione M, Toni D: The COX-2 G/C -765 polymorphism may modulate the occurrence of cerebrovascular ischemia. Blood Coagul Fibrinolysis 2006; 17: 93-96.
25. Liu LX, Zhou XY, Li CS, Liu LQ, Huang SY, Zhou SN: Selenoprotein S expression in the rat brain following focal cerebral ischemia. Neurol Sci 2013; 34: 1671-1678.
26. Alanne M, Kristiansson K, Auro K, Silander K, Kuulasmaa K, Peltonen L, Salomaa V, Perola M: Variation in the selenoprotein S gene locus is associated with coronary heart disease and ischemic stroke in two independent Finnish cohorts. Hum Genet 2007; 122: 355-365.
27. Kazma R, Mefford JA, Cheng I, Plummer SJ, Levin AM, Rybicki BA, Casey G, Witte JS: Association of the innate immunity and inflammation pathway with advanced prostate cancer risk. PLoS One 2012; 7:e51680.
28. Loza MJ, McCall CE, Li L, Isaacs WB, Xu J, Chang BL: Assembly of inflammation-related genes for pathway-focused genetic analysis. PLoS One 2007; 2:e1035.
29. Yang J, Lee SH, Goddard ME, Visscher PM: GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet 2011; 88: 76-82.
30. Yang J, Benyamin B, McEvoy BP, Gordon S, Henders AK, Nyholt DR, Madden PA, Heath AC, Martin NG, Montgomery GW, Goddard ME, Visscher PM: Common SNPs explain a large proportion of the heritability for human height. Nat Genet 2010; 42: 565-569.
31. Pasaniuc B, Zaitlen N, Lettre G, Chen GK, Tandon A, Kao WH, Ruczinski I, Fornage M, Siscovick DS, Zhu X, Larkin E, Lange LA, Cupples LA, Yang Q, Akylbekova EL, Musani SK, Divers J, Mychaleckyj J, Li M, Papanicolaou GJ, Millikan RC, Ambrosone CB, John EM, Bernstein L, Zheng W, Hu JJ, Ziegler RG, Nyante SJ, Bandera EV, Ingles SA, Press MF, Chanock SJ, Deming SL, Rodriguez-Gil JL, Palmer CD, Buxbaum S, Ekunwe L, Hirschhorn JN, Henderson BE, Myers S, Haiman CA, Reich D, Patterson N, Wilson JG, Price AL: Enhanced statistical tests for GWAS in admixed populations: assessment using African Americans from CARe and a Breast Cancer Consortium. PLoS Genet 2011; 7:e1001371.
32. So HC, Li M, Sham PC: Uncovering the total heritability explained by all true susceptibility variants in a genome-wide association study. Genet Epidemiol 2011; 35: 447-456.
33. Kang HM, Sul JH, Service SK, Zaitlen NA, Kong SY, Freimer NB, Sabatti C, Eskin E: Variance component model to account for sample structure in genome-wide association studies. Nat Genet 2010; 42: 348-354.
34. Almasy L, Blangero J: Multipoint quantitative- trait linkage analysis in general pedigrees. Am J Hum Genet 1998; 62: 1198-1211.
35. Harrison SC, Smith AJ, Jones GT, Swerdlow DI, Rampuri R, Bown MJ, Folkersen L, Baas AF, de Borst GJ, Blankensteijn JD, Price JF, van der Graaf Y, McLachlan S, Agu O, Hofman A, Uitterlinden AG, Franco-Cereceda A, Ruigrok YM, van't Hof FN, Powell JT, van Rij AM, Casas JP, Eriksson P, Holmes MV, Asselbergs FW, Hingorani AD, Humphries SE: Interleukin-6 receptor pathways in abdominal aortic aneurysm. Eur Heart J 2013; 34: 3707-3716.
36. Biros E, Walker PJ, Nataatmadja M, West M, Golledge J: Downregulation of transforming growth factor, beta receptor 2 and Notch signaling pathway in human abdominal aortic aneurysm. Atherosclerosis 2012; 221: 383-386.
37. Drumm ML, Konstan MW, Schluchter MD, Handler A, Pace R, Zou F, Zariwala M, Fargo D, Xu A, Dunn JM, Darrah RJ, Dorfman R, Sandford AJ, Corey M, Zielenski J, Durie P, Goddard K, Yankaskas JR, Wright FA, Knowles MR: Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 2005; 353: 1443-1453.
38. Marousi S, Ellul J, Antonacopoulou A, Gogos C, Papathanasopoulos P, Karakantza M: Functional polymorphisms of interleukin 4 and interleukin 10 may predict evolution and functional outcome of an ischaemic stroke. Eur J Neurol 2011; 18: 637-643.
39. Devan WJ, Falcone GJ, Anderson CD, Jagiella JM, Schmidt H, Hansen BM, Jimenez- Conde J, Giralt-Steinhauer E, Cuadrado-Godia E, Soriano C, Ayres AM, Schwab K, Kassis SB, Valant V, Pera J, Urbanik A, Viswanathan A, Rost NS, Goldstein JN, Freudenberger P, Stogerer EM, Norrving B, Tirschwell DL, Selim M, Brown DL, Silliman SL, Worrall BB, Meschia JF, Kidwell CS, Montaner J, Fernandez-Cadenas I, Delgado P, Greenberg SM, Roquer J, Lindgren A, Slowik A, Schmidt R, Woo D, Rosand J, Biffi A: Heritability estimates identify a substantial genetic contribution to risk and outcome of intracerebral hemorrhage. Stroke 2013; 44: 1578-1583.